Paul E. Eliadis
Paul E. Eliadis publishes mostly in Genetics, Oncology and Hematology, on topics such as Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments and Lymphoma Diagnosis and Treatment.
- World rank
- #2,748,678 of 7,710,434 ranked researchers
- Rank in Australia
- #75,842 of 140,210
- Works
- 24
- Citations
- 1.1k
- Citations per work
- 47.0
What does Paul E. Eliadis research?
Paul E. Eliadis's work is mostly in Medicine (79%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1978.8%
- Medicine1978.8%
- Everything else521.2%
- 1Genetics20% of their works
- 2Oncology17% of their works
- 3Hematology17% of their works
- 4Pathology and Forensic Medicine12% of their works
- 5Pulmonary and Respiratory Medicine9% of their works
- 6Hepatology4% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Lymphoma Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Surgical Treatments
- Cutaneous lymphoproliferative disorders research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Which keywords describe Paul E. Eliadis's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, BCR-ABL, Classification, Imatinib and Lymphoma.
- Mycosis Fungoides
- JAK2 Mutation
- Cutaneous Lymphomas
- Preoperative Chemoradiotherapy
- Hepatocellular Carcinoma
- Lymphoma
- Classification
- Genomic Aberrations
- Prognostic Factors
- Rituximab
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Imatinib
- Clinical Practice Guidelines
- Liver Cancer
- Rectal Cancer
- Hereditary Angioedema
- Kinin Receptor Family
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Rituximab162 topics
- Prognostic Factors112 topics
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
- BCR-ABL71 topic
- Classification71 topic
- Imatinib71 topic
- Lymphoma71 topic
- Clinical Practice Guidelines62 topics
- Hepatocellular Carcinoma31 topic
- Liver Cancer31 topic
- Preoperative Chemoradiotherapy31 topic
- Rectal Cancer31 topic
- Cutaneous Lymphomas21 topic
- Hereditary Angioedema21 topic
- JAK2 Mutation21 topic
- Kinin Receptor Family21 topic
- Mycosis Fungoides21 topic
- Myelofibrosis21 topic
Where does Paul E. Eliadis work?
Paul E. Eliadis's main affiliation in the publication record is Wesley Hospital, Australia.
How many publications and citations does Paul E. Eliadis have?
OpenAlex counts 24 works and 1,128 citations for Paul E. Eliadis, an h-index of 10, ranking #2,748,678 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paul E. Eliadis. Posts are plain text and can be reported.